- New biosimilar adalimumab - Hyrimoz(R)2018 | Second Faculty of Medicine
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Adalimumab biosimilars in the therapy of Crohn's disease and ulcerative colitis: Prospective multicentric clinical monitoring2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine